Last edition
News about "Indian Pharmacopoeia 2026"
IP 2026 Conclave Highlights Pharmacopoeial Standards for Pharma Quality
The Indian Pharmacopoeia Commission (IPC) strengthens industry preparedness for IP 2026 through awareness, capacity-building, stakeholder engagement, and adoption of pharmacopoeial standards for quality-assured medicines.
Indian Pharmacopoeia 2026 | 11/06/2026 | By News Bureau
Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.
Indian Pharmacopoeia 2026 | 16/05/2026 | By News Bureau | 117
Health Minister JP Nadda Unveils 10th Indian Pharmacopoeia
The Union Health Minister highlighted the Indian Pharmacopoeia’s recognition in 19 Global South countries, India’s rise to eighth globally in WHO pharmacovigilance, and key updates in IP 2026, including 121 new monographs and the first inclusion of blood component standards.
Indian Pharmacopoeia 2026 | 02/01/2026 | By News Bureau | 259
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy